Breaking News

Centrient Pharmaceuticals to Acquire Astral SteriTech

Brings in-house manufacturing capabilities for high-quality sterile antibiotic powder injectable finished dosage forms with two FDA-approved production lines.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Centrient Pharmaceuticals has signed an agreement for the acquisition of Astral SteriTech Private Limited, an international manufacturer specialized in sterile antibiotic injectable finished dosage forms. With the acquisition of Astral SteriTech, Centrient strengthens its position in beta-lactam antibiotics.   The products offered by Astral SteriTech are sterile injectable finished dosage forms for Semi-Synthetic Cephalosporins and Semi-Synthetic Penicillins. Being close to Centrient’s core prod...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters